AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ARIX BIOSCIENCE PLC

Major Shareholding Notification Jan 24, 2024

4968_mrq_2024-01-24_496ddeb9-b056-459b-ba52-c3b19793e1f3.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

Arix Bioscience PLC (ARIX)

Holding(s) in Company

24-Jan-2024 / 17:30 GMT/BST


TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Arix Bioscience Plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name RTW Investments, LP
City and country of registered office (if applicable) New York, USA
4. Full name of shareholder(s) (if different from 3.) v
Name RTW Biotech Opportunities Operating Ltd
City and country of registered office (if applicable) St Peter Port, Guernsey
5. Date on which the threshold was crossed or reached vi: 17/01/2024
6. Date on which issuer notified (DD/MM/YYYY): 22/01/2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached 25.52 0.00% 25.52% 33,023,210
Position of previous notification (if

applicable)
n/a n/a n/a
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of

shares

ISIN code (if possible)
Number of voting rights ix % of voting rights
Direct

(DTR5.1)
Indirect

 (DTR5.2.1)
Direct

(DTR5.1)
Indirect

(DTR5.2.1)
GB00BD045071 0 33,023,210 0.00% 25.52%
SUBTOTAL 8. A 33,023,210 25.52%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument Expiration

date x
Exercise/

Conversion Period xi
Number of voting rights that may be acquired if the instrument is

exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument Expiration

date x
Exercise/

Conversion Period xi
Physical or cash

Settlement xii
Number of voting rights % of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
Roderick Wong
RTW Investments GP LLC
RTW Investments, LP
RTW Biotech Opportunities Ltd
RTW Biotech Opportunities Operating Ltd 25.52% 0.00% 25.52%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi
Place of completion London, UK
Date of completion 19/01/2024

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


ISIN: GB00BD045071
Category Code: HOL
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.3. Major shareholding notifications
Sequence No.: 299502
EQS News ID: 1822379
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1822379&application_name=news&site_id=fca~~~70305e72-f59f-461a-b2d0-16f922a5fd99

Talk to a Data Expert

Have a question? We'll get back to you promptly.